knowledge -WSS

knowledge

author：entertainment 2025-10-02 00:28:41 - browse：74167

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： New company forms to vet health AI models, root out weaknesses

WSS

Eat, drink, but be wary — 4 foods that interact with medications

SCOTUS questions limit to govt efforts to fight misinformation

Future doctors should be trained to promote social change

Intermittent fasting comes with a heart risk? Not so fast

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

hotspot

knowledge

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Parkland mass shooting to be reenacted for lawsuit

Wildfire smoke exposes gaps in outdoor worker protections

Climate activists disrupt London Pride march to protest corporate sponsorship

Malaria cases in Florida and Texas: Here’s what you need to know

Health AI adoption puts security, privacy startups on investors' radar

DIEP, the 'gold standard' of breast reconstruction, is under threat

Argenx readies a blockbuster opportunity with drug for autoimmune disease

focus

App could help diagnose ear infections more accurately — and at home

Methadone treatment changes are coming. Do they go far enough?

Virtual Event: March of the Biosimilars

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Methadone treatment changes are coming. Do they go far enough?

AstraZeneca to buy developer of next

focus

leisure time

leisure time

Wikipedia